Delivery Order SPE2DB22D2009-SPE2DB25FL6TY

Award Date 12/5/24
Potential Completion Date 12/6/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL6TY
    Delivery Order

This federal contract award, valued at $1,185.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific products being delivered under this contract include MUCUS RLF DM ER 600-30 MG TAB 20S, which are likely prescription medications used for the treatment of various medical conditions. The contract does not have a set-aside designation, indicating open competition. This contract award demonstrates Amerisourcebergen's extensive experience and capabilities in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 3/6/25, 9:52 AM